专利检索 ap:("Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C") AND inv:"Chung-Hsin Yeh" 第 1 页

1.

发明申请
COMPLEX, CONTRAST AGENT AND METHOD FOR TREATING A DISEASE RELATED TO CXCR4 RECEPTOR 有权

公开(公告)号：US20220125761A1

公开(公告)日：2022-04-28

申请号：US17126364

申请日：2020-12-18

申请人： Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C

发明人： Chien-Chung Hsia , Chung-Hsin Yeh , Cheng-Liang Peng , Chun-Tang Chen

IPC分类号： A61K31/395 , C01G15/00

摘要： Disclosed herein is a complex, a contrast agent and the method for treating a disease related to CXCR4 receptor. The complex is configured to bind the CXCR4 receptor, and is used as a medicament for diagnosis and treatment of cancers and other indications related to the CXCR4 receptor.

2.

发明授权
Complex, contrast agent and method for treating a disease related to CXCR4 receptor 有权

公开(公告)号：US11951091B2

公开(公告)日：2024-04-09

申请号：US17126364

申请日：2020-12-18

申请人： Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C

发明人： Chien-Chung Hsia , Chung-Hsin Yeh , Cheng-Liang Peng , Chun-Tang Chen

IPC分类号： A61K31/395 , C01G15/00

CPC分类号： A61K31/395 , C01G15/00

摘要： Disclosed herein is a complex, a contrast agent and the method for treating a disease related to CXCR4 receptor. The complex is configured to bind the CXCR4 receptor, and is used as a medicament for diagnosis and treatment of cancers and other indications related to the CXCR4 receptor.